Medlab partners up to develop and distribute cannabis drug for cancer pain

Medlab partners up to develop and distribute cannabis drug for cancer pain

Australian cannabis company Medlab (ASX: MDC) has teamed up with Canadian pharmaceutical company Pharmascience to develop and distribute a medicinal cannabis product aimed at treating pain in cancer patients.

The two companies will research and develop NanaBis, a cannabis based drug that uses Medlab's proprietary spray delivery system.

Nanbis is a side of cheek spray currently in the second stage of an Australian advanced cancer pain trial, available under the federal special access scheme and currently before several agencies for fast track approval.

CEO of Medlab Sean Hall says the partnership will speed up the development and distribution of the new drug not just in Australia but around the world.

"NanaBis is in an exciting stage of its development as the company looks to fast track global drug approval pathways," says Hall.

"This agreement signifies real intent and interest for a true global pharmaceutical company to enter legitimate science as it relates to cannabis that has been research focused into a serious condition: cancer pain."

The partnership will first see Medlab able to get into the US and Canadian markets faster, following on from success in Australia.

Pharmascience is the fourth largest generic pharmaceutical company in Canada with over 1,500 employees worldwide.

Based in Montreal the company distributes and develops products to patients and healthcare professionals in more than 60 countries.

Medlab was named the number four top cannabis company in Australia by Business News Australia in 2018.

Shares in Medlab are up 15.49 per cent to $0.41 per share at 10.07am AEDT.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

How P2C can help retailers maintain brand loyalty amid the supply chain crisis
Partner Content
With the ongoing supply chain crisis expected to continue throughout 2022, retailers ar...
Productsup
Advertisement

Related Stories

Brian Hartzer-helmed fintech Beforepay dives 42 per cent on ASX debut

Brian Hartzer-helmed fintech Beforepay dives 42 per cent on ASX debut

Today’s debut of ‘Pay on Demand’ platform Beforep...

Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

Bod to launch UK clinical trial into medicinal cannabis efficacy on long COVID

With an estimated 1.3 million people in the United Kingdom sufferin...

Australian-owned Rhythm Japan acquired by leading North American snowsports retailer

Australian-owned Rhythm Japan acquired by leading North American snowsports retailer

Rhythm Japan, an Australian-owned Japan-based snowsports retailer, ...

NSW announces $43 million lifeline for cancelled major events and festivals

NSW announces $43 million lifeline for cancelled major events and festivals

The New South Wales government has today established a $43 million ...